# Blood Pressure Management in Stroke Following Endovascular Treatment

> **NCT04484350** · PHASE2 · COMPLETED · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 30 (actual)

## Conditions studied

- Stroke, Acute
- Vessels; Occlusion
- Blood Pressure
- Endovascular Thrombectomy
- Mechanical Thrombectomy

## Interventions

- **DRUG:** Labetalol
- **DRUG:** Hydralazine
- **DRUG:** Enalapril

## Key facts

- **NCT ID:** NCT04484350
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-23
- **Primary completion:** 2023-02-04
- **Final completion:** 2023-05-04
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04484350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04484350, "Blood Pressure Management in Stroke Following Endovascular Treatment". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04484350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*